The Stanley Center for Psychiatric Research at Broad Institute of MIT and Harvard is a multi-disciplinary biomedical research program located in Cambridge, Massachusetts that studies the biological basis of psychiatric disease.
[2] Within a year of its inception, researchers at the center and their international collaborators published a paper on their analysis of a collection of more than 7,000 genetic samples for schizophrenia.
[4] In early 2012, Scolnick stepped down as director and became the Stanley Center's chief scientist.
[5] In July 2014, the Broad Institute announced that Ted Stanley had committed an additional $650 million to the center.
"[7] The announcement coincided with the publication of a paper by Stanley Center researchers and collaborators, as part of the Psychiatric Genomics Consortium, that identified over 100 regions in the human genome associated with schizophrenia through the genetic analysis of 110,000 cases and controls.